Raymond James & Associates’s Tritium DCFC Limited Ordinary Shares DCFC Stock Holding History

Raymond James & Associates’s Portfolio DCFC Stock Details DCFC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-139	Closed	-$1.49K	–	4130
2024 Q1	$1.49K	Sell	139 -2	-1%	-$49	﹤0.01%	3912
2023 Q4	$6.2K	Sell	141 -21	-13%	-$995	﹤0.01%	3812
2023 Q3	$9.83K	Buy	162 +5	+3%	+$952	﹤0.01%	3764
2023 Q2	$34.3K	Buy	157 +3	+2%	+$651	﹤0.01%	3734
2023 Q1	$39.5K	Buy	154 +2	+1%	+$586	﹤0.01%	3750
2022 Q4	$50.9K	Sell	152 -18	-11%	-$6.63K	﹤0.01%	3717
2022 Q3	$109K	Buy	170 +14	+9%	+$17.5K	﹤0.01%	3596
2022 Q2	$190K	Sell	156 -105	-40%	-$173K	﹤0.01%	3522
2022 Q1	$524K	Buy	+261	New	+$433K	﹤0.01%	3049

Other funds holding DCFC

WIA

Wetzel Investment Advisors Indianapolis, Indiana $252M AUM 18.78% 1-Year Est. Return

Raymond James & Associates's DCFC Position: Q2 2024 in Review

Raymond James & Associates sold out of Tritium DCFC Limited Ordinary Shares (DCFC) in Q2 2024, closing a stake of 139 shares — an estimated $1.49K sold.

Raymond James & Associates first reported a position in DCFC in Q1 2022 and held it in 9 quarters. The position peaked at $524K in Q1 2022. 1 fund tracked by Wall St. Rank holds DCFC as of Q2 2024.

Raymond James & Associates reported no remaining Tritium DCFC Limited Ordinary Shares position as of Q2 2024 after selling out during the quarter.
Raymond James & Associates sold 139 Tritium DCFC Limited Ordinary Shares shares in Q2 2024, an estimated $1.49K.
Raymond James & Associates first reported a position in Tritium DCFC Limited Ordinary Shares in Q1 2022 and held it in 9 quarters.
Raymond James & Associates's Tritium DCFC Limited Ordinary Shares position peaked at $524K in Q1 2022.
1 fund tracked by Wall St. Rank held Tritium DCFC Limited Ordinary Shares as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.